Sensus Healthcare, Inc. – NASDAQ:SRTS
Founder-led company
Sensus Healthcare stock price today
$3.2
-4.01
-55.62%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 7 hours
Sensus Healthcare stock price monthly change
+16.86%
month
Sensus Healthcare stock price quarterly change
+16.86%
quarter
Sensus Healthcare stock price yearly change
+188.40%
year
Sensus Healthcare key metrics
Market Cap | 113.41M |
Enterprise value | 60.08M |
P/E | 3.87 |
EV/Sales | 1.34 |
EV/EBITDA | 2.09 |
Price/Sales | 1.89 |
Price/Book | 1.75 |
PEG ratio | N/A |
EPS | 0.28 |
Revenue | 31.65M |
EBITDA | 5.89M |
Income | 4.65M |
Revenue Q/Q | 212.33% |
Revenue Y/Y | -15.83% |
Profit margin | 54.45% |
Oper. margin | 33.31% |
Gross margin | 66.53% |
EBIT margin | 33.31% |
EBITDA margin | 18.63% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSensus Healthcare stock price history
Sensus Healthcare stock forecast
Sensus Healthcare financial statements
| Jun 2023 | 4.52M | -380K | -8.39% |
|---|---|---|---|
| Sep 2023 | 3.89M | -1.45M | -37.22% |
| Dec 2023 | 12.56M | 4.21M | 33.5% |
| Mar 2024 | 10.66M | 2.27M | 21.33% |
| Sep 2025 | 7.3M | 162.71K | 2.23% |
|---|---|---|---|
| Oct 2025 | 6.7M | 326.36K | 4.87% |
| Dec 2025 | 13.9M | 3.58M | 25.83% |
| Mar 2026 | 9M | 976.26K | 10.85% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 52017000 | 6.00M | 11.55% |
|---|---|---|---|
| Sep 2023 | 50546000 | 5.95M | 11.79% |
| Dec 2023 | 53727000 | 4.88M | 9.09% |
| Mar 2024 | 57273000 | 6.06M | 10.59% |
| Jun 2023 | 742K | -29K | 0 |
|---|---|---|---|
| Sep 2023 | 442K | 31K | -39K |
| Dec 2023 | 2.66M | 187K | -7K |
| Mar 2024 | -8.18M | -233K | 0 |
Sensus Healthcare alternative data
| Aug 2023 | 42 |
|---|---|
| Sep 2023 | 42 |
| Oct 2023 | 42 |
| Nov 2023 | 42 |
| Dec 2023 | 42 |
| Jan 2024 | 42 |
| Feb 2024 | 42 |
| Mar 2024 | 35 |
| Apr 2024 | 35 |
| May 2024 | 35 |
| Jun 2024 | 35 |
| Jul 2024 | 35 |
Sensus Healthcare other data
35.02%
+4.46%
of SRTS is owned by hedge funds
73
+17
5.82M
+738.38K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Aug 2023 | 12000 | 0 |
| Sep 2023 | 10000 | 0 |
| May 2024 | 0 | 20000 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | HEINRICH JOHN director | Common Stock | 15,227 | $6.24 | $95,016 | ||
Sale | HEINRICH JOHN director | Common Stock | 4,773 | $5.95 | $28,399 | ||
Purchase | SARDANO JOSEPH C director, officer.. | Common Stock | 10,000 | $2.88 | $28,770 | ||
Purchase | SARDANO MICHAEL officer: PRESIDEN.. | Common Stock | 1,000 | $2.99 | $2,990 | ||
Purchase | SARDANO MICHAEL officer: PRESIDEN.. | Common Stock | 1,000 | $3.78 | $3,778 | ||
Purchase | SARDANO JOSEPH C director, officer.. | Common Stock | 10,000 | $3.86 | $38,570 | ||
Purchase | HEINRICH JOHN director | Common Stock | 10,000 | $2.86 | $28,600 | ||
Purchase | SARDANO JOSEPH C director, officer.. | Common Stock | 7,925 | $3 | $23,735 | ||
Purchase | O'REAR SAMUEL director | Common Stock | 17,564 | $3 | $52,674 | ||
Purchase | SARDANO JOSEPH C director, officer.. | Common Stock | 17,075 | $2.99 | $51,054 |
| Patent |
|---|
Grant Filling date: 18 Jul 2018 Issue date: 29 Jun 2021 |
Grant Filling date: 12 Jan 2013 Issue date: 8 Jun 2021 |
Grant Utility: Systems and methods for real time beam sculpting intra-operative-radiation-therapy treatment planning Filling date: 18 Oct 2019 Issue date: 9 Mar 2021 |
Application BALLOON APPLICATOR FOR DIRECTIONAL INTRAOPERATIVE AND BRACHY RADIATION THERAPY WITH CONFORMAL PHANTOM FOR 3D ANATOMICAL IMAGE REGISTRATION Filling date: 15 Jun 2020 Issue date: 17 Dec 2020 |
Application Filling date: 31 Mar 2020 Issue date: 23 Jul 2020 |
Application Filling date: 14 Jan 2020 Issue date: 16 Jul 2020 |
Grant Filling date: 13 Jul 2017 Issue date: 12 May 2020 |
Application SYSTEMS AND METHODS FOR REAL TIME BEAM SCULPTING INTRA-OPERATIVE-RADIATION-THERAPY TREATMENT PLANNING Filling date: 18 Oct 2019 Issue date: 23 Apr 2020 |
Grant Filling date: 30 Mar 2018 Issue date: 31 Mar 2020 |
Grant Filling date: 14 Apr 2017 Issue date: 24 Mar 2020 |
| Quarter | Transcript |
|---|---|
| Q1 2024 11 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 8 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 9 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 6 Aug 2023 | Q2 2023 Earnings Call Transcript |
Sensus Healthcare: Better Outcomes For Painful Procedures
MDA Breakout Stocks Week 2 - January 2023: High-Frequency Gainers To Give You An Edge
Sensus Healthcare: Best In The Industry With Significant Growth Prospects
Lantheus Holdings Rules The Medical Diagnostics Business World
Sensus Healthcare: A Buy In Honor Of Skin Cancer Awareness Month
Learning Lessons From 3 Stocks Flourishing In A Desperate Biotech Bear Market
Sensus Healthcare: Likely Post-Pandemic Sales Recovery Can Boost Share Price
-
What's the price of Sensus Healthcare stock today?
One share of Sensus Healthcare stock can currently be purchased for approximately $3.2.
-
When is Sensus Healthcare's next earnings date?
Unfortunately, Sensus Healthcare's (SRTS) next earnings date is currently unknown.
-
Does Sensus Healthcare pay dividends?
No, Sensus Healthcare does not pay dividends.
-
How much money does Sensus Healthcare make?
Sensus Healthcare has a market capitalization of 113.41M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 45.2% to 24.41M US dollars.
-
What is Sensus Healthcare's stock symbol?
Sensus Healthcare, Inc. is traded on the NASDAQ under the ticker symbol "SRTS".
-
What is Sensus Healthcare's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Sensus Healthcare?
Shares of Sensus Healthcare can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Sensus Healthcare's key executives?
Sensus Healthcare's management team includes the following people:
- Mr. Joseph C. Sardano Co-Founder, Chairman, Chief Executive Officer & Pres(age: 72, pay: $510,010)
- Mr. Stephen Cohen Co-Founder & Executive Vice President(age: 65, pay: $435,740)
- Mr. Michael J. Sardano Vice President, Gen. Counsel & Corporation Sec.(age: 37, pay: $261,070)
-
Is Sensus Healthcare founder-led company?
Yes, Sensus Healthcare is a company led by its founders Mr. Joseph C. Sardano and Mr. Stephen Cohen.
-
How many employees does Sensus Healthcare have?
As Jul 2024, Sensus Healthcare employs 35 workers.
-
When Sensus Healthcare went public?
Sensus Healthcare, Inc. is publicly traded company for more then 9 years since IPO on 26 Jul 2016.
-
What is Sensus Healthcare's official website?
The official website for Sensus Healthcare is sensushealthcare.com.
-
Where are Sensus Healthcare's headquarters?
Sensus Healthcare is headquartered at 851 Broken Sound Parkway NW, Boca Raton, FL.
-
How can i contact Sensus Healthcare?
Sensus Healthcare's mailing address is 851 Broken Sound Parkway NW, Boca Raton, FL and company can be reached via phone at +56 19225808.
Sensus Healthcare company profile:
Sensus Healthcare, Inc.
sensushealthcare.comExchange:
NASDAQ
Full time employees:
35
Industry:
Medical - Devices
Sector:
Healthcare
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
851 Broken Sound Parkway NW
Boca Raton, FL 33487
Boca Raton, FL 33487
CIK: 0001494891
ISIN: US81728J1097
CUSIP: 81728J109
